- Home
- PCVX vs SLNO Comparison
PCVX vs SLNO Comparison
Compare PCVX & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- SLNO
- Stock Information
- Founded
- PCVX 2013
- SLNO 1999
- Country
- PCVX United States
- SLNO United States
- Employees
- PCVX N/A
- SLNO N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PCVX Health Care
- SLNO Health Care
- Exchange
- PCVX Nasdaq
- SLNO Nasdaq
- Market Cap
- PCVX 4.0B
- SLNO 3.7B
- IPO Year
- PCVX 2020
- SLNO 2014
- Fundamental
- Price
- PCVX $41.81
- SLNO $46.98
- Analyst Decision
- PCVX Strong Buy
- SLNO Strong Buy
- Analyst Count
- PCVX 8
- SLNO 9
- Target Price
- PCVX $114.17
- SLNO $114.89
- AVG Volume (30 Days)
- PCVX 1.5M
- SLNO 2.2M
- Earning Date
- PCVX 11-04-2025
- SLNO 11-04-2025
- Dividend Yield
- PCVX N/A
- SLNO N/A
- EPS Growth
- PCVX N/A
- SLNO N/A
- EPS
- PCVX N/A
- SLNO N/A
- Revenue
- PCVX N/A
- SLNO $98,675,000.00
- Revenue This Year
- PCVX N/A
- SLNO N/A
- Revenue Next Year
- PCVX N/A
- SLNO $181.30
- P/E Ratio
- PCVX N/A
- SLNO N/A
- Revenue Growth
- PCVX N/A
- SLNO N/A
- 52 Week Low
- PCVX $27.66
- SLNO $41.50
- 52 Week High
- PCVX $107.31
- SLNO $90.32
- Technical
- Relative Strength Index (RSI)
- PCVX 51.58
- SLNO 31.94
- Support Level
- PCVX $39.87
- SLNO $66.12
- Resistance Level
- PCVX $45.90
- SLNO $69.99
- Average True Range (ATR)
- PCVX 1.93
- SLNO 3.71
- MACD
- PCVX -0.60
- SLNO -2.47
- Stochastic Oscillator
- PCVX 32.20
- SLNO 18.57
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.